25 Oesophageal Cancer

Oesophageal Cancer Brachytherapy

22

THE GEC ESTROHANDBOOKOF BRACHYTHERAPY | Part II Clinical Practice Version 1 - 10/06/2019

35. Makino T, Doki Y, Miyata H, et al. Use of (18)F-fluoro-deoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumour and lymph node metastasis in oesophageal squamous cell carcinoma. Surgery 2008 144 : 793-802. 36. Murakami Y, Nagata Y, Nishibuchi I, et al. Long-termoutcomes of intraluminal brachytherapy in combination with external beam radiotherapy for superficial oesophageal cancer. Int J Clin Oncol 2012; 17(3) : 263-71. 37. Nagami Y, Ominami M, Shiba M, et al. The five-year survival rate after endoscopic submucosal dissection for superficial oesophageal squamous cell neoplasia. Dig Liver Dis 2017 Apr; 49(4) : 427-233 38. Nemoto K, Yamada S, NishioM et al. Results of radiation therapy of superficial oesophageal cancer using the standard radiotherapy method recommended by the Japanese Society of Therapeutic Radiology and Oncology (JASTRO) Study Group. Anticancer Res 2006; 26(2B) : 1507-12. 39. Okawa T, Dokiya T, Nishio M, et al. Multi-institutional randomized trial of external radiotherapy with and without intraluminal brachytherapy for oesophageal cancer in Japan. Japanese Society of Therapuetic Radiology and Oncology (JASTRO) Study Group. Int J Radiat Oncol Biol Phys 1999 45(3) : 623-8. 40. Patonay P, Naszály A, Mayer A. Simultaneous radiochemotherapy and endoluminal HDR brachytherapy in oesophageal cancer. Strahlenther Onkol 2007; 183(2) : 94-8. 41. Pennathur A, Luketich JD: Resection for oesophageal cancer: strategies for optimal management. Ann Thorac Surg 2008; 85 : 751–756. 42. Raja S, Rice TW, Goldblum JR, et al. Oesophageal submucosa: the watershed for oesophageal cancer. J Thorac Cardiovasc Surg 2011; 142 : 1403-1411. 43. Rosenblatt E, Jones G, Sur RK, et al. Adding external beam to intra-luminal brachytherapy improves palliation in obstructive squamous cell oesophageal cancer: a prospective multi-centre randomized trial of the International Atomic Energy Agency. Radiother Oncol 2010, 97(3): 488-94. 44. Safaei AM, Ghalehtaki R, Khanjani N, et al. High-dose-rate intraluminal brachytherapy prior to external radiochemotherapy in locally advanced 45. Sanford NN, Catalano PJ, Enzinger PC, et al. A retrospective comparison of neoadjuvant chemoradiotherapy regimens for locally advanced oesophageal cancer. Dis Esophagus 2017; 30(7) : 1-8. 46. Schmid MP, Fokdal L, Westerveld H et al. GYN GEC-ESTRO target concept recommendations for image guided adaptive brachytherapy in primary vaginal cancer. Submitted to Radiother Oncol 2019. 47. Sjoquist KM, Burmeister BH, Smithers BM, et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol 2011; 12(7) : 681-92. 48. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H: Chemora- diation with and without surgery in patients with locally advanced squamous cell carcinoma of the oesophagus. J Clin Oncol 2005; 23 : 2310–17. 49. Sur RK, Donde B, Levin CV, et al. Fractionated high dose rate intraluminal brachytherapy in palliation of advanced oesophageal cancer. Int J Radiat Oncol Biol Phys 1998; 40 : 447-53. 50. Tamaki T, Ishikawa H, Takahashi T, et al. Comparison of efficacy and safety of low-dose-rate vs. high dose-rate intraluminal brachytherapy boost in patients with superficial oesophageal cancer. Brachytherapy 2012; 11(2) : 130-6. 51. Tangoku A, Yamamoto Y, Furukita Y, eta l. The new era of staging as a key for oesophageal cancer: preliminary results. J Contemp Brachytherapy 2017; 9(1) : 30-35.

53. Thosani N, Singh H, Kapadia A, et al. Diagnostic accuracy of EUS in differential mucosal versus submucosal invasion of superficial oesophageal cancers: a systematic review and meta-analysis. Gastrointest Endosc 2012; 75 : 242-53. 54. van Hagen P, Hulshof MC, van Lanschot JI, et al. Preoperative chemoradiotherapy for oesophageal or junctional cancer: an FNCLCC and FFCD multicenter phase III trial. N Engl J Med 2012; 366(22) : 2074-84. 55. Van Limbergen E, et al. Image guided (CT/MR) adaptive brachytherapy for anal cancer. Personal communication during 2016 World Congress of Brachytherapy. 2016. 56. van Vliet EP, Heijenbrok-Kal MH, Hnunink MG, et al. Staging investigations for oesophageal cancer: a metanalysis. Br J Cancer 2008; 98 : 547-57. 57. Vuong T, Szego P, David M, et al. The safety and usefulness of high-dose- rate endoluminal brachytherapy as a boost in the treatment of patients with oesophageal cancer with external beam radiation with or without chemotherapy. Int J Radiat Oncol Biol Phys 2005; 63(3) : 758-64. 58. Wieder HA, Brücher BL, Zimmermann F, et al. Time course of tumour metabolic activity during chemoradiotherapy of oesophageal squamous cell carcinoma and response to treatment. J Clin Oncol 2004 22 : 900-8. 59. Xia F, Mao J, Ding J, Yang H. Observation of normal appearance and wall thickness of oesophagus on CT images. Eur J Radiol 2009; 72(3) : 406-11. 60. Yang CS, Chen X, Tu S, Etiology and prevention of oesophageal cancer. Gastrointest Tumors 2016; 3(1) : 3-16. 61. Ychou M, Boige V, Pignon JP, et al. Perioperative chemotherapy compared with surgery alone for resectable gastro-oesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol 2011; 29(13) : 1715-21. 62. Yorozu A and Dokiya T. Brachytherapy – Techniques and evidences. Brachytherapy for oesophageal cancer: optimum doses and indications in the modern era. Springer Nature Singapore Pte Ltd. 2019; Chapter 21: 273-82. 63. Yorozu A, Toya K, Dokiya T. Long-term results of concurrent chemoradiotherapy followed by high dose rate brachytherapy for T2-3N0- 1M0 oesophageal cancer. Esophagus 2006; 3(1) : 1-5.

an appropriate treatment for oesophageal cancer. Ann Thorac Cardiovasc Surg 2012; 18(3) : 190-9.

52. Tessa M, Rotta P, Ragona R, et al. Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced oesophageal cancer: results of a retrospective multicentre study. Tumori 2005; 91(5) : 406-14.